Search

Your search keyword '"Brown, Julia M."' showing total 454 results

Search Constraints

Start Over You searched for: Author "Brown, Julia M." Remove constraint Author: "Brown, Julia M."
454 results on '"Brown, Julia M."'

Search Results

8. Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

9. Hiding in Plain Sight: The Globally Distributed Bacterial Candidate Phylum PAUC34f

10. Ancestral Absence of Electron Transport Chains in Patescibacteria and DPANN

11. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo

14. Evolutionary stasis of a deep subsurface microbial lineage

17. Rokubacteria: Genomic Giants among the Uncultured Bacterial Phyla

18. Species-resolved, single-cell respiration rates reveal dominance of sulfate reduction in a deep continental subsurface ecosystem.

19. Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

23. Draft genome sequence of marine alphaproteobacterial strain HIMB11, the first cultivated representative of a unique lineage within the Roseobacter clade possessing an unusually small genome

24. Protocolized care pathways in emergency general surgery: a systematic review and meta-analysis.

25. Major role of nitrite-oxidizing bacteria in dark ocean carbon fixation

28. Short-term outcomes of health-related quality of life in patients with locally recurrent rectal cancer: multicentre, international, cross-sectional cohort study

29. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

30. Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial

32. G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects

33. Recruiting to surgical trials in the emergency setting: using a mixed methods study to understand clinician and patient perspectives

34. Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts

35. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial

37. Life strategies for Aminicenantiain subseafloor oceanic crust

46. Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital

50. International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials: A qualitative study

Catalog

Books, media, physical & digital resources